Precision Medicine-Based Biomarkers For Traumatic Brain Injury

On-Demand Recording


Thanks for your interest in our recent webinar in partnership with The Scientist. Watch as Dr. Kevin Wang explores how matching the major TBI subphenotypes with precision medicine-based biomarkers is a promising tool for monitoring disease course, predicting patient outcome, and developing new therapies.

By submitting this form, you agree to Quanterix’s Terms of Use and Privacy Policy. In addition, you agree to receive information regarding Quanterix products and services. You will be able to unsubscribe at any time.